Metraipolis › archive › dc_04cc64413a35
A Multi-Targeting Chimeric Antigen Receptor-T Cell Platform to Overcome Antigen Heterogeneity in the Treatment of Non-Small Cell Lung Cancer — Europe PMC PMID:42801642
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42801642
- DOI
- 10.1002/advs.77992
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-07T20:45:54.915Z
- SHA-256 of the archived text
37ab1a4395aff4d7a428477fc4df4a86385d93577dae2b98e92d0dab04b56a4a- Stable URL of this page
https://metraipolis.com/documento/dc_04cc64413a35
How to cite
A Multi-Targeting Chimeric Antigen Receptor-T Cell Platform to Overcome Antigen Heterogeneity in the Treatment of Non-Small Cell Lung Cancer — Europe PMC PMID:42801642 — Europe PMC (en), https://europepmc.org/article/MED/42801642 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_04cc64413a35 (Metraipolis archive dc_04cc64413a35, sha256 37ab1a4395aff4d7a428477fc4df4a86385d93577dae2b98e92d0dab04b56a4a)
BibTeX
@misc{dc04cc64413a35,
title = {A Multi-Targeting Chimeric Antigen Receptor-T Cell Platform to Overcome Antigen Heterogeneity in the Treatment of Non-Small Cell Lung Cancer — Europe PMC PMID:42801642},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42801642},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_04cc64413a35; sha256 37ab1a4395aff4d7a428477fc4df4a86385d93577dae2b98e92d0dab04b56a4a},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42801642. Agents can read the archived copy with the MCP tool read_document.